Cargando…

Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma

This retrospective, single-institutional study investigated long-term outcome, toxicity and health-related quality of life (HRQoL) in meningioma patients after radiotherapy. We analyzed the data of 119 patients who received radiotherapy at our department from 1997 to 2014 for intracranial WHO grade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lisowski, Dominik, Trömel, Jannik, Lutyj, Paul, Lewitzki, Victor, Hartrampf, Philipp E., Polat, Bülent, Flentje, Michael, Tamihardja, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672325/ https://www.ncbi.nlm.nih.gov/pubmed/36396802 http://dx.doi.org/10.1038/s41598-022-24192-8

Ejemplares similares

Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms
por: Kraft, Johannes, et al.
Publicado: (2022)

Impact of Radiotherapy on Malfunctions and Battery Life of Cardiac Implantable Electronic Devices in Cancer Patients
por: Lisowski, Dominik, et al.
Publicado: (2023)

Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Complete loss of E-cadherin expression in a rare case of metastatic malignant meningioma: a case report
por: Lisowski, Dominik, et al.
Publicado: (2023)

Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Non-rigid image registration of 4D-MRI data for improved delineation of moving tumors
por: Weick, Stefan, et al.
Publicado: (2020)

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
por: Tamihardja, Jörg, et al.
Publicado: (2020)

Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
por: Hartrampf, Philipp E., et al.
Publicado: (2020)

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
por: Polat, Bülent, et al.
Publicado: (2022)

Comparison of treatment plans for hypofractionated high‐dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results
por: Wilbert, Jürgen, et al.
Publicado: (2010)

Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
por: Meniai-Merzouki, F., et al.
Publicado: (2018)

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
por: Hemmati, Saman Moritz, et al.
Publicado: (2019)

Dosimetric Evaluation of Commercially Available Flat vs. Self-Produced 3D-Conformal Silicone Boluses for the Head and Neck Region
por: Pollmann, Stephan, et al.
Publicado: (2022)

Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
por: Grzbiela, Hanna, et al.
Publicado: (2023)

Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer
por: Polat, Bülent, et al.
Publicado: (2017)

Radiotherapy for meningiomas
por: Chen, William C., et al.
Publicado: (2022)

Spontaneous Intracranial Hemorrhage Associated With an Intracranial Meningioma
por: Ferrufino-Mejia, Bill R, et al.
Publicado: (2023)

Long Term Outcome and Quality of Life of Intracranial Meningioma Patients Treated with Pencil Beam Scanning Proton Therapy
por: Krcek, Reinhardt, et al.
Publicado: (2023)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy
por: Nguyen, Eric K., et al.
Publicado: (2021)

Intracranial plasmacytoma mimicking meningioma
por: Anoop, T. M., et al.
Publicado: (2014)

Intracranial Meningioma-induced Parkinsonism
por: Kim, Ji-In, et al.
Publicado: (2014)

Impact of beam configuration on VMAT plan quality for Pinnacle(3)Auto-Planning for head and neck cases
por: Richter, Anne, et al.
Publicado: (2019)

Distress and quality of life do not change over time in patients with operated and conservatively managed intracranial meningioma
por: Kalasauskas, Darius, et al.
Publicado: (2021)

External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors
por: Lewitzki, Victor, et al.
Publicado: (2019)

MENINGIOMA-03 FUNCTIONAL OUTCOME AFTER SURGERY FOR INTRACRANIAL MENINGIOMA AT THE KENYATTA NATIONAL HOSPITAL
por: Kagasi, Travor, et al.
Publicado: (2023)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2021)

Radiotherapy and radiosurgery for meningiomas
por: Chen, William C, et al.
Publicado: (2023)

Clinical Outcomes Following Re-Operations for Intracranial Meningioma
por: Richardson, George E., et al.
Publicado: (2021)

Olfactory Delusional Syndrome and Intracranial Meningioma
por: Rotondo, Michele, et al.
Publicado: (2011)

Vertebral metastases from intracranial meningioma
por: Zaghouani, H, et al.
Publicado: (2014)

Management of intracranial meningiomas in Enugu, Nigeria
por: Mezue, Wilfred C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g6fo200m24b3rkdttr002ls9ps